Lyell Immunopharma (LYEL) Revenue (2020 - 2026)
Lyell Immunopharma (LYEL) posted Revenue of $2000.0 for Q1 2026, down 66.67% sequentially from $6000.0 in Q4 2025, and down 71.43% YoY from $7000.0 in Q1 2025.
Lyell Immunopharma (LYEL) Revenue (2020 - 2026) Analysis & Trends
Lyell Immunopharma has reported Revenue for 7 years, with the latest figure at $2000.0 in Q1 2026.
- Quarterly Revenue fell 71.43% year-over-year to $2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31000.0 (down 52.31% YoY) and the FY2025 annual result came in at $36000.0, down 40.98% from the prior year.
- Revenue fell to $2000.0 in Q1 2026 per LYEL's latest filing, from $6000.0 in the prior quarter.
- Over five years, Revenue peaked at $48.4 million in Q4 2022 and troughed at $2000.0 in Q1 2026.
- A 5-year average of $5.0 million and a median of $13000.0 in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue soared 1614.6% in 2022, then tumbled 99.97% in 2023.
- Over 5 years, Revenue stood at $48.4 million in 2022, then sank by 99.97% to $13000.0 in 2023, then decreased by 15.38% to $11000.0 in 2024, then sank by 45.45% to $6000.0 in 2025, then slumped by 66.67% to $2000.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $2000.0, $6000.0, and $15000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Lyell Immunopharma | 326.39 Mn | 326.39 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 27,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Dec 31, 2022 | 48.39 Mn |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 35.74 Mn |
| Mar 31, 2022 | 553,000.00 |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 2.76 Mn |